PIETRANGELO, Antonello
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 35.373
EU - Europa 18.225
AS - Asia 17.418
SA - Sud America 2.578
AF - Africa 365
OC - Oceania 71
Continente sconosciuto - Info sul continente non disponibili 22
AN - Antartide 1
Totale 74.053
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 34.766
SG - Singapore 5.238
CN - Cina 4.925
GB - Regno Unito 4.725
IT - Italia 4.017
SE - Svezia 3.392
BR - Brasile 2.026
HK - Hong Kong 1.903
VN - Vietnam 1.767
DE - Germania 1.455
FI - Finlandia 1.246
KR - Corea 849
UA - Ucraina 740
FR - Francia 688
RU - Federazione Russa 610
BD - Bangladesh 597
TR - Turchia 526
IN - India 394
CA - Canada 326
BG - Bulgaria 302
NL - Olanda 270
ID - Indonesia 225
AR - Argentina 199
MX - Messico 159
JP - Giappone 150
IQ - Iraq 141
PL - Polonia 104
ZA - Sudafrica 98
BE - Belgio 92
PK - Pakistan 87
ES - Italia 84
IE - Irlanda 84
AE - Emirati Arabi Uniti 81
MY - Malesia 71
CO - Colombia 69
EC - Ecuador 69
AT - Austria 67
AU - Australia 63
LT - Lituania 62
CL - Cile 60
VE - Venezuela 56
EG - Egitto 52
RO - Romania 49
PH - Filippine 48
CH - Svizzera 40
UZ - Uzbekistan 40
MA - Marocco 39
SA - Arabia Saudita 38
IR - Iran 37
TH - Thailandia 36
DZ - Algeria 34
KE - Kenya 30
PY - Paraguay 30
TN - Tunisia 29
IL - Israele 27
PE - Perù 27
CZ - Repubblica Ceca 26
BO - Bolivia 25
JM - Giamaica 25
JO - Giordania 25
NP - Nepal 24
GR - Grecia 22
OM - Oman 22
CR - Costa Rica 21
KZ - Kazakistan 19
PT - Portogallo 19
TW - Taiwan 19
AZ - Azerbaigian 17
ET - Etiopia 17
HU - Ungheria 17
SI - Slovenia 17
RS - Serbia 15
UY - Uruguay 14
HN - Honduras 13
LB - Libano 13
PS - Palestinian Territory 13
SK - Slovacchia (Repubblica Slovacca) 13
AL - Albania 11
DK - Danimarca 11
SY - Repubblica araba siriana 11
BY - Bielorussia 10
CI - Costa d'Avorio 10
DO - Repubblica Dominicana 10
EU - Europa 10
NG - Nigeria 10
PA - Panama 10
KG - Kirghizistan 9
SN - Senegal 9
CY - Cipro 8
GE - Georgia 8
KH - Cambogia 8
QA - Qatar 8
TT - Trinidad e Tobago 8
XK - ???statistics.table.value.countryCode.XK??? 8
AM - Armenia 7
GT - Guatemala 7
LV - Lettonia 7
AO - Angola 6
BH - Bahrain 6
MD - Moldavia 6
Totale 73.933
Salva come PNG Salva come JPEG
Città #
Ashburn 3.475
Fairfield 3.380
Southend 3.205
Singapore 3.182
Santa Clara 2.844
Woodbridge 2.261
Hong Kong 1.878
Hefei 1.857
Stockholm 1.817
Chandler 1.794
Houston 1.793
Jacksonville 1.388
San Jose 1.290
Wilmington 1.153
Seattle 1.149
Cambridge 1.050
Ann Arbor 969
Dearborn 969
Helsinki 956
Chicago 931
London 845
Nyköping 828
Seoul 800
Beijing 789
Los Angeles 601
Ho Chi Minh City 598
Council Bluffs 537
Modena 537
The Dalles 477
Hanoi 413
San Diego 374
Milan 366
New York 366
Dallas 362
Princeton 301
Sofia 279
Buffalo 236
Eugene 236
Lauterbourg 231
Berlin 211
Izmir 204
São Paulo 203
Moscow 193
Rome 192
Shanghai 187
Munich 170
Des Moines 158
Jakarta 153
Bologna 145
Redwood City 145
Salt Lake City 143
Frankfurt am Main 115
Orem 107
Phoenix 104
Tokyo 99
Columbus 98
Toronto 97
Amsterdam 90
Bremen 88
Da Nang 88
Warsaw 81
Falls Church 77
Montreal 76
Brussels 72
Parma 71
Elk Grove Village 68
Porto Alegre 68
Boardman 67
Philadelphia 66
Dublin 65
Chennai 64
Rio de Janeiro 62
Tampa 62
Brooklyn 61
Ottawa 61
Atlanta 60
Yalova 60
Haiphong 59
Kent 58
Baghdad 54
Nuremberg 53
San Francisco 53
Johannesburg 52
Nanjing 52
Paris 52
Florence 51
Mexico City 51
Guangzhou 48
Denver 47
Norwalk 47
Belo Horizonte 46
Fremont 45
Turku 45
Naples 44
Dhaka 43
Brasília 42
Miano 42
Redondo Beach 42
San Mateo 41
Turin 41
Totale 51.756
Salva come PNG Salva come JPEG
Nome #
Alterations in iron status predict cardiac response to blood transfusion in -thalassemia major 1.823
Terapia antialadosteronica e prevenzione della cardiomiopatia cirrotica 709
04093 Portal hypertension in advanced protoporphyric hepatopathy: a case report 484
04092 Liver function, iron status, and hemopoiesis in erythropoietic protoporphyria (EPP): insights into a complex interplay 475
Tocilizumab in patients with severe COVID-19: a retrospective cohort study 455
Coproporphyrin excretion in healthy newborn babies 440
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with Covid-19 pneumonia. 435
Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis 423
Iron overload in Africans and African-Americans and a common mutation in the SCL40A1 (ferroportin 1) gene 421
Non-HFE Hepatic Iron Overload. 419
Gluconeogenic Signals Regulate Iron Homeostasis via Hepcidin in Mice. 409
Clinical and molecular epidemiology of erythropoietic protoporphyria in Italy 402
Clinical impact of application of risk assessment models (Padua Prediction Score and Improve Bleeding Score) on venous thromboembolism, major hemorrhage and health expenditure associated with pharmacologic VTE prophylaxis: a “real life” prospective and retrospective observational study on patients hospitalized in a Single Internal Medicine Unit (the STIME study) 399
Hereditary hemochromatosis--a new look at an old disease. 398
Unravelling the Complexity of Inherited Retinal Dystrophies Molecular Testing: Added Value of Targeted Next-Generation Sequencing 395
Primary hypoparathyroidism is common in adult patients with b-thalassemia and protect patients from osteoporosis. 391
Safety and efficacy of sucrosomal iron in inflammatory bowel disease patients with iron deficiency anemia 390
Association between celiac disease and idiopathic dilated cardiomyopathy: a case report. 389
Ferroportin disease: Pathogenesis, diagnosis and treatment 387
Impact of safety-related dose reductions or discontinuations on sustained virologic response in HCV-infected patients: Results from the GUARD-C Cohort 380
Human macrophage ferroportin biology and the basis for the ferroportin disease 375
Ceruloplasmin gene variants are associated with hyperferritinemia and increased liver iron in patients with {NAFLD} 374
Better prognosis in females with severe COVID-19 pneumonia: possible role of inflammation as potential mediator. 362
ER stress controls iron metabolism through induction of hepcidin. 356
Capitolo 31 "Malattia di Wilson ed emocromatosi", in Sezione V "Malattie del fegato" 356
Hepatitis C virus-induced reactive oxygen species raise hepatic iron level in mice by reducing hepcidin transcription 355
BMP-6 is a Key Endogenous Regulator of Hepcidin Expression and Iron Metabolism 355
Bone Morphogenetic Protein Signaling Is Impaired in an Hfe Knockout Mouse Model of Hemochromatosis. 355
Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene 354
Hepcidin expression does not rescue the iron-poor phenotype of Kupffer cells in Hfe-null mice after liver transplantation. 349
Activin B induces noncanonical SMAD1/5/8 signaling via BMP type I receptors in hepatocytes: Evidence for a role in hepcidin induction by inflammation in male mice 348
A Phase 1/2, Dose-Escalation Trial of Deferasirox for the Treatment of Iron Overload in HFE-Related Hereditary Hemochromatosis. 337
Juvenile hemochromatosis associated with pathogenic mutations of adult hemochromatosis genes 336
Duodenal ferritin synthesis in genetic hemochromatosis 336
HYPERHOMOCYSTEINEMIA AND MTHFR C677T POLYMORPHISM IN PATIENTS WITH PORTAL VEIN THROMBOSIS COMPLICATING LIVER CIRRHOSIS 336
First and second wave among hospitalized COVID-19 patients with severe pneumonia: a comparison of 28-day mortality over 1-year pandemic in a tertiary university hospital in Italy. 336
Antiviral treatment profoundly affects iron status in HCV patients: Implications for management and treatment outcome 334
An unfortunate case of post-ERCP complications 334
IS FLOW-MEDIATED DILATATION (FMD) ASSESSMENT A RELIABLE MARKER OF ENDOTHELIAL DYSFUNCTION IN LIVER CIRRHOSIS? 334
MARKERS OF ENDOTHELIAL DYSFUNCTION AS PREDICTORS OF ASCITIC DECOMPENSATION IN PATIENTS WITH LIVER CIRRHOSIS. 333
The role of the iron responsive element in the control of ferroportin1/IREG1/MTP1 gene expression 331
Hypoxia induced downregulation of hepcidin is mediated by platelet derived growth factor BB 330
BMP6 treatment compensates for the molecular defect and ameliorates hemochromatosis in Hfe knockout mice. 328
Kupffer cells and macrophages are not required for hepatic hepcidin activation during iron overload 327
Serum and Liver Iron Differently Regulate the Bone Morphogenetic Protein 6 (BMP6)-SMAD Signaling Pathway in Mice 327
Frequency and biochemical expression of C282Y/H63D hemochromatosis (HFE) gene mutations in the healthy adult population in Italy 327
Haptoglobin modifies the hemochromatosis phenotype in mice 325
Hepatic stellate cells are not subjected to oxidant stress during iron-induced fibrogenesis in rodents 324
Hepatocellular Carcinoma in HIV-infected Patients: Check Ealy, Treat Hard 324
Comorbidity does not mean clinical complexity: evidence from the RePoSI register 324
Heterogeneity of hemochromatosis in Italy 322
A PAIR OF BROTHERS WITH ACERULOPLASMINEMIA DUE TO A NOVEL NONSENSE MUTATION: UNUSUAL PHENOTYPE AND EFFECTIVENESS OF IRON-CHELATION THERAPY BY DEFERASIROX 322
Albumin gene expression is down-regulated by albumin or macromolecule infusion in the rat. 321
Platelet count does not predict bleeding in cirrhotic patients: Results from the PRO-LIVER Study 318
Haemochromatosis 318
ANTIALDOSTERONE THERAPY IN LIVER CIRRHOSIS: A ROLE FOR PREVENTION OF CIRROTHIC CARDIOMIOPATHY? 315
VITAMIN-E SUPPLEMENTATION PREVENTS HEPATIC CIRRHOSIS DUE TO IRON OVERLOAD IN RODENTS 314
Iron removal therapy in porphyria cutanea tarda: phlebotomy versus slow subcutaneous desferrioxamine infusion 313
DNA repair in lymphocytes from humans and rats with chronic iron overload. 311
Enhanced hepatic collagen type I mRNA expression into fat-storing cells in a rodent model of hemochromatosis. 311
Hereditary Hemochromatosis: Pathogenesis, Diagnosis, and Treatment 311
MOLECULAR AND CELLULAR ASPECTS OF IRON-INDUCED HEPATIC CIRRHOSIS IN RODENTS 309
The SMAD pathway is required for hepcidin response during endoplasmic reticulum stress 309
3-hydroxy-(4H)-benzopyran-4-ones as potential iron chelating agents in vivo 308
Antialdosterone therapy in liver cirrhosis: a role for prevention of cirrhitc cardiomiopathy ? 308
Hepatitis B virus DNA integration in tumour tissue of a non-cirrhotic HFE-haemochromatosis patient with hepatocellular carcinoma. 304
MTHFR C677T polymorhism and hyperhomocysteinemia in patients with liver cirrhosis complicated by portal vein thrombosis and hepatocellular carcinoma 302
Lipid composition and fluidity of liver plasma membranes from rats with chronic dietary iron overload. 301
The impact of inherited thrombophilia on liver transplantation. 301
Altered hepatic BMP signaling pathway in human HFE hemochromatosis 300
HIV INFECTION AND SURVIVAL IN PATIENTS WITH HCCAND LIVER CIRRHOSIS 300
C/EBP-beta/LAP controls down-regulation of albumin gene transcription during liver regeneration 300
Iron and steatohepatitis. 298
Expression of the duodenal iron transporters divalent-metal transporter 1 and ferroportin 1 in iron deficiency and iron overload 297
Liver gene expression during chronic dietary iron overload in rats 294
Missed treatment in an Italian HBV infected patients cohort: HBV RER 294
Hyperhomocysteinemia in patients with acute porphyrias: A potentially dangerous metabolic crossroad? 292
Excess iron into hepatocytes is required for activation of collagen type I gene during experimental siderosis 291
Magnetic resonance imaging to identify classic and nonclassic forms of ferroportin disease 291
Current challenges in the management of patients with sickle cell disease - A report of the Italian experience 289
Prolonged higher dose methylprednisolone vs. conventional dexamethasone in COVID-19 pneumonia: a randomised controlled trial (MEDEAS) 288
Prevalence Of Subclinical Liver Fibrosis Among Patients With Idiopathic Pulmonary Fibrosis 286
Diacerhein blocks iron regulatory protein activation in inflamed human monocytes 285
Disease progression and liver cancer in the ferroportin disease 285
Genetics, Genetic Testing, and Management of Hemochromatosis: 15 Years since Hepcidin 285
Challenges in diagnosis and management of acute hepatic porphyrias: from an uncommon pediatric onset to innovative treatments and perspectives 285
Antioxidant activity of silybin in vivo during long-term iron overload in rats 282
Lack of enterocyte iron accumulation in the ferroportin disease 280
Regulation of transferrin, transferrin receptor, and ferritin genes in human duodenum 280
Standard or branched-chain amino acid infusions as short-term nutritional support in liver cirrhosis? 276
Modulation of the synthesis of apolipoproteins in rat hepatoma cells. 275
Flow-mediated dilatation (FMD) assessment as a marker of endothelial dysfunction in liver cirrhosis 275
Hereditary hemochromatosis in adults without pathogenic mutations in the hemochromatosis gene 275
Subclinical liver fibrosis in patients with idiopathic pulmonary fibrosis 272
Serum ferritin as a predictor of treatment outcome in patients with chronic hepatitis C 270
Reducing the risk of hospital admission: A call to action from the Italian Society of Internal Medicine 268
Clinical factors associated with death in 3044 COVID-19 patients managed in internal medicine wards in Italy: results from the SIMI-COVID-19 study of the Italian Society of Internal Medicine (SIMI) 268
Huh-7: a human hemochromatotic cell line. 267
Thyroid volume in adult beta-thalassemic patients is smaller than in controls 266
THE MOLECULAR BASIS FOR THE HEPATIC REGULATION OF HEPCIDIN, THE IRON HORMONE, BY BONE MORPHOGENETIC PROTEINS. 264
Totale 34.942
Salva come PNG Salva come JPEG
Categoria #
all - tutte 274.897
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 274.897
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021421 0 0 0 0 0 0 0 0 0 0 0 421
2021/20225.494 284 581 517 380 223 271 393 295 619 436 861 634
2022/20235.388 612 563 348 504 647 824 114 592 645 86 244 209
2023/20243.601 169 221 511 298 529 273 301 425 133 188 192 361
2024/202512.875 675 150 341 856 2.182 1.813 773 698 1.227 768 1.768 1.624
2025/202625.733 1.709 1.253 2.283 2.289 2.710 2.089 3.031 1.244 4.417 2.305 1.654 749
Totale 74.449